Clinical trials
Completed Breast Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
618 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 12 |
| 2002 | 10 |
| 2003 | 14 |
| 2004 | 20 |
| 2005 | 18 |
| 2006 | 37 |
| 2007 | 32 |
| 2008 | 33 |
| 2009 | 31 |
| 2010 | 29 |
| 2011 | 37 |
| 2012 | 29 |
| 2013 | 33 |
| 2014 | 32 |
| 2015 | 40 |
| 2016 | 28 |
| 2017 | 27 |
| 2018 | 31 |
| 2019 | 26 |
| 2020 | 21 |
| 2021 | 20 |
| 2022 | 19 |
| 2023 | 13 |
| 2024 | 15 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 618 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 49 |
| Novartis Pharmaceuticals | 35 |
| UNICANCER | 26 |
| Institut du Cancer de Montpellier - Val d'Aurelle | 22 |
| AstraZeneca | 19 |
| Centre Oscar Lambret | 19 |
| Institut Curie | 18 |
| European Organisation for Research and Treatment of Cancer - EORTC | 16 |
| Pfizer | 16 |
| Institut Bergonié | 15 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 618 |
| Neoplasm Metastasis | 53 |
| Neoplasms | 49 |
| Lung Neoplasms | 19 |
| Prostatic Neoplasms | 18 |
| Ovarian Neoplasms | 14 |
| Colorectal Neoplasms | 12 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Colonic Neoplasms | 10 |
| Melanoma | 10 |
Trials
Showing 1 to 25 of 618. Each trial links to its page on Pharma Observatory.
518 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.